Trubion Pharmaceuticals, Inc. (TRBN)
$3.80
-0.05 (-1.30%)
| CAPS Rating |
|
|---|---|
| Open | $3.90 |
| Previous Close | $3.85 |
| Daily Range | $3.80 - $3.90 |
| 52-Week Range | $1.00 - $6.75 |
| Market Cap | $77.38M |
| P/E Ratio | 6.13 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 13,954 |
| Average Daily Volume | 15,000 |
TRBN
VS S&P 500 (SPY)
This ticker is not currently Ratable.
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
TRBN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
TRBN News and Commentary
- Takeover Likely? Management Says No! – The Motley Fool
Related News and Articles
- A Big Upgrade for Allos Therapeutics – The Motley Fool
- Now's a Great Time to Invest -- So Don't Blow It Like This – The Motley Fool
- This Stock Is a Train Wreck – The Motley Fool
- Drug Lowers Cholesterol; Stock Follows – The Motley Fool
- The Hottest Sector for 2010 – The Motley Fool
- Abbott: Brave or Stupid? – The Motley Fool
- 5-Star Stocks Poised to Pop: American Oriental Bioengineering – The Motley Fool
- Do You Have the Guts to Buy? – The Motley Fool
- This Top Stock Is a Winner – The Motley Fool
- Amylin Scores a Hat Trick – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- Finally Convinced? Benlysta Works! – The Motley Fool
- Winners and Losers of the House Health-Care Reform Bill – The Motley Fool
- Earnings? Yawn. Trial Data? Moving! – The Motley Fool
- Small and Volatile, but Not for Long – The Motley Fool
- Saved by Emerging Markets. Sort Of. – The Motley Fool
RSS Headlines
Fool UK
